SCHEMBL3301588

SCHEMBL3301588

CCOc1ccc([SiH](O[SiH](c2ccc(OCC)c(CC)c2)c2ccc(OCC)c(CC)c2)c2ccc(OCC)c(CC)c2)cc1CC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
NPSR1 Q6W5P4 1/20 0.43
ALDH1A1 P00352 6/20 0.38
KDM4E B2RXH2 3/20 0.38
HSD17B10 Q99714 2/20 0.37
NPC1 O15118 1/20 0.37
USP2 O75604 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
POLB P06746 2/20 0.36
SRD5A2 P31213 1/20 0.36
TSHR P16473 1/20 0.36
CREBBP Q92793 1/20 0.36
GAA P10253 1/20 0.35
MAPK1 P28482 2/20 0.35
GRK6 P43250 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C19 P33261 1/20 0.35
MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3296512 0.86 L3MBTL1 (0.43) MAPTL3MBTL1NPSR1ALDH1A1KDM4E
SCHEMBL3299672 0.85 MAPT (0.39) MAPTL3MBTL1NPSR1ALDH1A1KDM4E
SCHEMBL3296118 0.84 TAAR1 (0.42) L3MBTL1ALDH1A1KDM4EHSD17B10MEN1
SCHEMBL3297865 0.83 MAPT (0.42) MAPTL3MBTL1ALDH1A1KDM4EHSD17B10
SCHEMBL3297050 0.80 ESR1 (0.43) MAPTL3MBTL1ALDH1A1KDM4EHSD17B10
SCHEMBL3299978 0.79 GRIN2D (0.31)
SCHEMBL3294405 0.76 GRK6 (0.36) MAPTL3MBTL1ALDH1A1KDM4EHSD17B10
SCHEMBL3294484 0.76 KMT2A (0.40) MAPTL3MBTL1NPSR1ALDH1A1KDM4E
SCHEMBL9886101 0.73 MAPT (0.60) MAPTL3MBTL1NPSR1ALDH1A1KDM4E
SCHEMBL326803 0.73 NQO1 (0.52) MAPTL3MBTL1NPSR1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7741393-B2 Organic silicon-based compound and method of producing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-22 US disclosed
US-20070203275-A1 Organic Silicon-Based Compound And Method Of Producing The Same SUMITOMO CHEMICAL COMPANY, LIMITED 2007-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070203275-A1 Organic Silicon-Based Compound And Method Of Producing The Same ARSA, OR10J3, HDAC10 MAPT 2685/4885L3MBTL1 1173/4885NPSR1 3028/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.